Clinical Trials List
Protocol Number99-3989A
2011-08-01 - 2015-07-31
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林衛邑 Division of Rehabilitation Medicine
- Yi-Hsin Weng Division of Rehabilitation Medicine
- Tzu-Chen Yen Division of Nuclear Medicine
- 陸清松 Division of Rehabilitation Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
0 participants
